On March 28, 2024, Opaleye Management Inc. filed a Schedule 13G with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in iBio Inc. The filing revealed that Opaleye Management holds 650,000 shares of iBio Inc., which represents 7.63% of the company's issued and outstanding common stock. The shares are reported to have shared voting and dispositive power. This disclosure is based on the number of shares outstanding as reported by iBio Inc. on its Form 10-Q filed with the SEC on April 1, 2024. The filing by Opaleye Management, a Massachusetts-based entity, is a routine regulatory requirement indicating ownership exceeding five percent of a company's shares and does not necessarily suggest an intention to influence or change the control of iBio Inc.

On March 28, 2024, Opaleye Management Inc. filed a Schedule 13G with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in iBio Inc. The filing revealed that Opaleye Management holds 650,000 shares of iBio Inc., which represents 7.63% of the company's issued and outstanding common stock. The shares are reported to have shared voting and dispositive power. This disclosure is based on the number of shares outstanding as reported by iBio Inc. on its Form 10-Q filed with the SEC on April 1, 2024. The filing by Opaleye Management, a Massachusetts-based entity, is a routine regulatory requirement indicating ownership exceeding five percent of a company's shares and does not necessarily suggest an intention to influence or change the control of iBio Inc.